0.7 %The prevalence of a new HIV diagnosis was 0.7% (2 of 301) among patients with cancer in a cohort attending a tertiary hospital in Nairobi, Kenya, between February 2021 and September 2021.
KenyaVIH/sidaobserved February 2021 to September 2021published 2023JCO global oncologyPubMeddocument of 8 observations
14 %The upper boundary of HIV seroprevalence was 14% among the 171 cancer cases meeting at least one strength-of-evidence criterion for HIV infection/AIDS.
Kenyacancer (non précisé) · VIH/sidaobserved August 1 to October 31, 2011published 2014PloS oneeurope_pmcdocument of 4 observations
44,628 individualsThe number of active children living with HIV on treatment at the end of US Government fiscal year 2019 was 44,628.
KenyaVIH/sidaobserved FY 2019published 2025The Pediatric infectious disease journalPubMeddocument of 10 observations
2 foldHIV-1 subtype D infection is associated with a >2-fold higher risk of death than subtype A infection.
KenyaVIH/sidapublished 2007The Journal of infectious diseaseseurope_pmcdocument of 2 observations
0 casesNo women acquired HIV during the study period.
KenyaVIH/sidapublished 2024Journal of the International AIDS SocietyPubMeddocument of 8 observations
243 recordsOf the 1,154 medical records abstracted, 243 (21%) were from adolescent girls and young women seeking HIV prevention services.
KenyaVIH/sidapublished 2023Frontiers in public healthPubMeddocument of 9 observations
56.9 pg/mlThe median (IQR) levels of TGF-β were 56.9 (50.0–67.8) pg/ml in pLLV participants and 27.7 (19.5–34.7) pg/ml in virally suppressed participants on first-line cART.
KenyaVIH/sidapublished 2025The Pan African medical journalPubMeddocument of 11 observations
76 %At enrolment, 536 (76%) of 704 participants had documented virological suppression.
KenyaVIH/sidapublished 2022The Lancet. Child & adolescent healthPubMeddocument of 12 observations
50 %In the SEARCH Study in rural Kenya and Uganda (2013–2017), 50% of HIV-positive persons had viral suppression at baseline according to unadjusted estimates.
KenyaVIH/sidaobserved 2013-2017published 2020Epidemiology (Cambridge, Mass.)PubMeddocument of 8 observations
Nationally, improvements in under-five mortality after 2006 were associated with a decline in the prevalence of HIV and malaria, increase in access to better sanitation, fever treatment-seeking rates and maternal autonomy.
Kenyapaludisme · VIH/sidaobserved after 2006published 2021BMC medicineeurope_pmcdocument of 7 observationsDOI 10.1186/s12916-021-01974-x
5.9 percentage_pointsAmong people with HIV aged ≥40 years (n = 3036), the prevalence of blood pressure ≥140/90 mmHg decreased by 5.9 percentage points (95% CI 3.0%, 8.8%).
Kenyahypertension artérielle · VIH/sidapublished 2025Journal of the International AIDS SocietyPubMeddocument of 11 observations
81.5 %Among unsuppressed participants, 81.5% had evidence of any major HIV drug-resistance mutation in Kenya from 2018 to 2020.
KenyaVIH/sidaobserved 2018-2020published 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 5 observations
2.77 mL/m²People living with HIV had 2.77 mL/m² larger left atrial volume compared with the HIV-negative group after adjusting for risk factors associated with diastolic dysfunction.
KenyaVIH/sidapublished 2022Open heartPubMeddocument of 9 observations
63 samplesSixty-three out of 80 HIV-positive individuals on antiretroviral therapy in Teso, Western Kenya had successful sequencing of the partial pol gene.
KenyaVIH/sidaobserved 2019published 2021The Pan African medical journalPubMeddocument of 7 observations
51 %Among 607 survey responders (86% of 704 seroconverters), 51% of women reported a spouse as the suspected infection source.
KenyaVIH/sidapublished 2021PloS onePubMeddocument of 16 observations
3.2 %Among 5200 under-5 deaths with an assigned cause in the CHAMPS network, 164 (3.2%) had HIV in the causal chain.
KenyaVIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations
14 %Among people with a PrEP indication and an HIV test in the past 3 months, the median proportion of people on PrEP was 14% with no DCP.
KenyaVIH/sidapublished 2025The lancet. HIVPubMeddocument of 11 observations
36.2 %The mean guideline adherence score for preexposure prophylaxis (PrEP) care was 36.2% at control sites.
KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 9 observations
0 casesNo instances of HIV, syphilis, or hepatitis C were identified in the tested blood samples.
Kenyahépatite C · syphilis · VIH/sidapublished 2026Global health, epidemiology and genomicsPubMeddocument of 3 observations
8 daysTime to enhanced adherence counseling following detection of high viral load was reduced by a median of 8 days, from 49 days to 41 days before versus after implementation of the standardized enhanced adherence counseling package.
KenyaVIH/sidapublished 2022MedicinePubMeddocument of 12 observations
31 %Mean predicted risk probability among pregnant and postpartum women with HIV with a new HIV diagnosis was 31% in the low-risk quintile.
KenyaVIH/sidapublished 2025AIDS and behaviorPubMeddocument of 13 observations
47.5 daysTime to completion of at least 3 enhanced adherence counseling sessions was 47.5 days after implementation of the standardized enhanced adherence counseling package.
KenyaVIH/sidapublished 2022MedicinePubMeddocument of 12 observations
91.4 %Among children eligible for antiretroviral therapy (ART) after HIV diagnosis via family-centered index testing in Kenya, 91.4% initiated ART.
KenyaVIH/sidaobserved 2015–2016published 2020International journal of STD & AIDSPubMeddocument of 7 observations
1.29 aORDelayed HIV PCR testing for early infant diagnosis was associated with an adjusted odds ratio of 1.29 for yielding a positive result.
KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 11 observations
5.8 per_100_person-yearsThe incidence of first incident pregnancies among female sex workers living with HIV in Mombasa, Kenya was 5.8 per 100 person-years between October 2012 and April 2017.
KenyaVIH/sidaobserved October 2012-April 2017published 2020Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 10 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.